Medicine, Nephrology Division

Grants

Grants per year 1999 2005 2011 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2031

• 62 Active
• 262 Finished

Grants per year

Search results

• Active

  Prot #ACT18064: A Parallel-Group Treatment, Phase 2a, Multicenter, Randomized, Double-Blind, PlaceboControlled Umbrella Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, and Rilzabrutinib in Participants Aged 16 to 75 Years with Primary

  Peleg, Y. A. (PD/PI)

  ICON Clinical Research, LLC, Sanofi US Services Inc.

  2/6/25 → 2/6/28

  Project: Research project

• Prot #STU00222754: Simergent Archimedes Peritoneal Dialysis System Human Factors Summative Study Protocol

  Aggarwal, V. (PD/PI)

  Nemera Insight Chicago LLC, Simergent, LLC

  1/10/25 → 1/10/26

  Project: Research project

• Exploring the Piezo1-Itga9 Axis in Schlemm’s Canal Development and Giant Vacuole Formation

  Quaggin, S. E. (PD/PI)

  Association for Research in Vision and Ophthalmology

  1/1/25 → 12/31/25

  Project: Research project

• Prot #VX21-147-301: A Phase 2/3 Adaptive, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Adult and Pediatric Subjects With APOL1-Mediated Proteinuric Kidney Disease

  Ghossein, C. (PD/PI)

  Vertex Pharmaceuticals Incorporated

  12/13/24 → 12/13/27

  Project: Research project

• Prot #1378-0006: EASi-KIDNEY: Studies of Heart & Kidney Protection with BI 690517 in Combination with Empagliflozin: A Multicenter, International, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517

  Isakova, T. (PD/PI)

  Duke University, Boehringer Ingelheim Pharmaceuticals, Inc.

  10/7/24 → 10/7/27

  Project: Research project

• Compartment-specific manipulation of NAD+ to mitigate post-injury kidney disease.

  Kapitsinou, P. (PD/PI) & Chandel, N. (Co-Investigator)

  National Institute on Aging

  9/30/24 → 8/31/26

  Project: Research project

• Cellular-level Vascular Oculomics (CVO) for monitoring systemic vascular health

  Fawzi, A. A. (PD/PI), Arispe, L. (Other), Isakova, T. (Other) & Weintraub, S. (Other)

  Office of the Director, National Institutes of Health

  9/15/24 → 9/14/25

  Project: Research project

• Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation

  Friedewald, J. J. (PD/PI)

  Cedars-Sinai Medical Center, National Institute of Allergy and Infectious Diseases

  9/1/24 → 8/31/31

  Project: Research project

• Prot #MLS-101-206: A Phase 2 Study to Evaluate the Efficacy and Safety of Lorundrostat Alone, and Lorundostat in Combination with Dapagliflozin, in Adults with Hypertension and Chronic Kidney Disease with Albuminuria

  Mehta, R. C. (PD/PI)

  Mineralys Therapeutics, Inc.

  8/11/24 → 8/11/25

  Project: Research project

• Endothelial oxygen sensing and metabolic reprogramming in AKI to CKD transition

  Kapitsinou, P. (PD/PI), Chandel, N. (Co-Investigator) & Thorp, E. B. (Co-Investigator)

  National Institute of Diabetes and Digestive and Kidney Diseases

  8/1/24 → 5/31/28

  Project: Research project

• Mosaic Loss of the Y Chromosome in Cardiac Amyloidosis

  Jin, J. (PD/PI) & Liu, P. (Other)

  University of Virginia, National Institute on Aging

  4/15/24 → 1/31/29

  Project: Research project

• Prot #R5459-RT-1956: A Noninterventional Extension Study for Patients Treated in Study R5459-RT-1944 with REGN5459 or REGN5458 (BCMA x CD3 Bispecific Antibodies) Who Receive a Kidney Transplant

  Friedewald, J. J. (PD/PI)

  Parexel, Regeneron Pharmaceuticals, Inc.

  4/10/24 → 4/10/27

  Project: Research project

• Underlying immunometabolic molecular mechanisms of cardiac dysfunction and HFpEF

  Thorp, E. B. (PD/PI), Chandel, N. (Co-Investigator) & Quaggin, S. E. (Co-Investigator)

  American Heart Association

  4/1/24 → 3/31/28

  Project: Research project

• Prot #TVTX-RE021-204: A Multicentered, Single-Group Phase 2, Exploratory, OpenLabel Study to Investigate Safety and Effect of Sparsentan in Combination with Sodium Glucose Cotransporter-2 (SGLT2) Inhibition in the Treatment of Adult Participants with Immu

  Wadhwani, S. (PD/PI)

  George Clinical Pty Ltd., Retrophin, Inc.

  2/27/24 → 2/27/27

  Project: Research project

• Prot #CAB-201-001: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) in Subjects with Active Systemic Lupus Erythematosus

  Blanco, I. (PD/PI), Wadhwani, S. (PD/PI) & Wadhwani, S. (PD/PI)

  Cabaletta Bio, Inc.

  2/26/24 → 8/30/27

  Project: Research project

• Prot #KZR‑616‑202: A Phase 2b, Randomized, Controlled Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Zetomipzomib (KZR-616) 30 mg or 60 mg with Placebo in Patients with Active Lupus Nephritis

  Peleg, Y. A. (PD/PI) & Wadhwani, S. (PD/PI)

  PPD Investigator Services, LLC, Kezar Life Sciences, Inc.

  1/26/24 → 1/26/27

  Project: Research project

• Calciprotein Particles and Vascular Calcification in Patients with Chronic Kidney Disease

  Isakova, T. (PD/PI)

  Albert Einstein College of Medicine, National Heart, Lung, and Blood Institute

  1/1/24 → 12/31/28

  Project: Research project

• Development and Pilot Testing of Hypertension Management Support with EHR-Integrated Telemonitoring and Proactive Patient Messaging for Patients at High Risk from Hypertension

  Persell, S. D. (PD/PI), Nishi, L. J. (Co-Investigator), Paparello, J. J. (Co-Investigator) & Petito, L. C. (Other)

  Omron Healthcare Co., Ltd.

  11/1/23 → 3/31/25

  Project: Research project

• Prot #APL2-C3G‐310: A Phase 3, Randomized, Placebo‐Controlled, Double‐Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Immune‐Complex Membranoproliferative Glomerulonephritis

  Peleg, Y. A. (PD/PI)

  Worldwide Clinical Trials, Inc., Apellis Pharmaceuticals, Inc.

  9/25/23 → 9/25/26

  Project: Research project

• 13/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center

  Gallon, L. (PD/PI) & Gallon, L. (PD/PI)

  Wake Forest University Health Sciences, National Institute of Diabetes and Digestive and Kidney Diseases

  9/5/23 → 5/31/28

  Project: Research project

• Improving access to renal transplantation for Underserved Black Communities

  Kershaw, K. N. (PD/PI), Ladner, D. P. (PD/PI), Simpson, D. C. (PD/PI), Alexandria, S. J. (Co-Investigator), Beidas, R. S. (Co-Investigator), Blemur, P. (Co-Investigator), Franklin, J. E. (Co-Investigator), Lewis, M. W. (Co-Investigator), Zhao, L. (Co-Investigator) & Zhao, L. (Co-Investigator)

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/1/23 → 6/30/28

  Project: Research project

• Biomed Core

  Kapitsinou, P. (Other), Kapitsinou, P. (Other) & Scott, E. A. (Other)

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/1/23 → 6/30/28

  Project: Research project

• Administrative Core - Main

  George, A. L. (PD/PI), George, A. L. (PD/PI), Judge, S. M. (PD/PI), Judge, S. M. (PD/PI), Quaggin, S. E. (PD/PI) & Quaggin, S. E. (PD/PI)

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/1/23 → 6/30/28

  Project: Research project

• Continuation of the Chronic Renal Insufficiency Cohort (CRIC)

  Isakova, T. (PD/PI)

  University of Pennsylvania, National Institute of Diabetes and Digestive and Kidney Diseases

  8/15/23 → 6/30/28

  Project: Research project

• Prot #BGB‐3111‐309: A Phase 2/3, Multicenter, Randomized, Active‐Controlled, Open‐label Study to Evaluate the Efficacy and Safety of Zanubrutinib in Patients With Primary Membranous Nephropathy

  Peleg, Y. A. (PD/PI)

  BeiGene USA, Inc.

  8/9/23 → 8/9/26

  Project: Research project